| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 5791837
[patent_doc_number] => 20020162127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Human protein kinase domain-containing protein'
[patent_app_type] => new
[patent_app_number] => 10/060841
[patent_app_country] => US
[patent_app_date] => 2002-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 37490
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20020162127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060841 | Human protein kinase domain-containing protein | Jan 29, 2002 | Abandoned |
Array
(
[id] => 418816
[patent_doc_number] => 07276488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Vector system'
[patent_app_type] => utility
[patent_app_number] => 10/060585
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 22974
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276488.pdf
[firstpage_image] =>[orig_patent_app_number] => 10060585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/060585 | Vector system | Jan 28, 2002 | Issued |
| 09/937182 | Materials and methods relating to modulation of p66 expression | Jan 17, 2002 | Abandoned |
| 09/743173 | Enhanced delivery of nucleic acid- based drugs | Jan 13, 2002 | Abandoned |
Array
(
[id] => 6856683
[patent_doc_number] => 20030130184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Methods of inducing cell death'
[patent_app_type] => new
[patent_app_number] => 10/047990
[patent_app_country] => US
[patent_app_date] => 2002-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 9469
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130184.pdf
[firstpage_image] =>[orig_patent_app_number] => 10047990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/047990 | Methods of inducing cell death | Jan 13, 2002 | Abandoned |
Array
(
[id] => 1123754
[patent_doc_number] => 06794368
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-21
[patent_title] => 'Composition and method for inducing apoptosis in prostate cancer cells'
[patent_app_type] => B1
[patent_app_number] => 09/937643
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 5964
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794368.pdf
[firstpage_image] =>[orig_patent_app_number] => 09937643
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/937643 | Composition and method for inducing apoptosis in prostate cancer cells | Jan 9, 2002 | Issued |
| 09/914840 | Application of dna vectors for the treatment of viral infection | Jan 1, 2002 | Abandoned |
Array
(
[id] => 793125
[patent_doc_number] => 06982170
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-03
[patent_title] => 'Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1'
[patent_app_type] => utility
[patent_app_number] => 10/022554
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27051
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982170.pdf
[firstpage_image] =>[orig_patent_app_number] => 10022554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/022554 | Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 | Dec 16, 2001 | Issued |
Array
(
[id] => 6715492
[patent_doc_number] => 20030026840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Combinations for introducing nucleic acids into cells'
[patent_app_type] => new
[patent_app_number] => 10/023317
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22330
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023317
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023317 | Combinations for introducing nucleic acids into cells | Dec 16, 2001 | Abandoned |
Array
(
[id] => 6765259
[patent_doc_number] => 20030099657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Drug-heteropolymers'
[patent_app_type] => new
[patent_app_number] => 09/991798
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 235
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099657.pdf
[firstpage_image] =>[orig_patent_app_number] => 09991798
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/991798 | Drug-heteropolymers | Nov 25, 2001 | Abandoned |
Array
(
[id] => 6802505
[patent_doc_number] => 20030097670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Expression of polypeptides in rod outer segment membranes'
[patent_app_type] => new
[patent_app_number] => 09/990185
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9918
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20030097670.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990185
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990185 | Expression of polypeptides in rod outer segment membranes | Nov 20, 2001 | Abandoned |
Array
(
[id] => 5985733
[patent_doc_number] => 20020098503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes'
[patent_app_type] => new
[patent_app_number] => 09/999003
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12726
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098503.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999003 | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes | Nov 14, 2001 | Pending |
Array
(
[id] => 5935419
[patent_doc_number] => 20020061298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Method for optimally delivering virus to a solid tumor mass'
[patent_app_type] => new
[patent_app_number] => 09/987687
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6414
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061298.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987687
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987687 | Method for optimally delivering virus to a solid tumor mass | Nov 14, 2001 | Abandoned |
Array
(
[id] => 170394
[patent_doc_number] => 07662619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Sol-fusin: use of GP64-6His to catalyze membrane fusion'
[patent_app_type] => utility
[patent_app_number] => 10/416979
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8893
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416979
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416979 | Sol-fusin: use of GP64-6His to catalyze membrane fusion | Nov 14, 2001 | Issued |
Array
(
[id] => 141577
[patent_doc_number] => 07691567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin'
[patent_app_type] => utility
[patent_app_number] => 10/021753
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 59923
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021753
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021753 | Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin | Oct 29, 2001 | Issued |
| 09/700259 | Gene therapy vectors and their use in antitumor therapy | Oct 29, 2001 | Abandoned |
Array
(
[id] => 6678435
[patent_doc_number] => 20030228576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof'
[patent_app_type] => new
[patent_app_number] => 10/035300
[patent_app_country] => US
[patent_app_date] => 2001-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10039
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035300 | Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof | Oct 25, 2001 | Issued |
Array
(
[id] => 6769965
[patent_doc_number] => 20030215905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/013928
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192264
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013928 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 24, 2001 | Abandoned |
Array
(
[id] => 7369244
[patent_doc_number] => 20040006219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/013920
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192211
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10013920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013920 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 24, 2001 | Abandoned |
Array
(
[id] => 6809082
[patent_doc_number] => 20030199021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/013924
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 188406
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013924 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 24, 2001 | Abandoned |
